Expert Interviews

Rana Hamdy, MD, discussed her session at the 2024 AAP meeting, highlighting treatment duration with antibiotics for community-acquired pneumonia as well as the importance of understanding amoxicillin allergy.

John Loiselle, MD, FAAP, discusses pediatric musculoskeletal injuries, focusing on growth plates and age-specific anatomy at the 2024 AAP Conference.

Lori Byron, MD, emphasizes the harmful effects of extreme heat and wildfire smoke on children's health, urging education, sustainability, and collective action.

Andrew Dauber, MD, MMSc, of Children's National Hospital joined us to discuss potential advantages of LUM-201 as it goes through the clinical pipeline.

The panel examines potential long-term effects of central precocious puberty treatment on bone density and spermatogenesis in male patients.

Experts offer recommendations for supporting central precocious puberty patients in managing the social stigma and challenges associated with their condition.

Experts address common misconceptions about the timing of central precocious puberty treatment initiation and discontinuation, highlighting research on outcomes for therapy started before age 7 and continued beyond age 12.

Linda DiMeglio, MD, MPH, joined us to discuss the “Consensus Guidance for Monitoring Persons with Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes."

Andrew Dauber, MD, MMSc, of Children's National Hospital joined us to talk PGHD and the role of the pediatrician when it comes to treatment.

Alan Percy, MD, discusses where the general provider comes in when treating Rett syndrome and prescribing trofinetide (Daybue).

Alan Percy, MD, discussed what the FDA approval of trofinetide (Daybue) has meant to patients with Rett syndrome aged 2 years and older.

Pediatric endocrinologists explore comprehensive, individualized treatment strategies for Central Precocious Puberty that extend beyond considerations of chronological and bone age.

The panel examines the efficacy and safety profiles of gonadotropin-releasing hormone analogue (GnRHa) treatments in managing Central Precocious Puberty.

Key opinion leaders analyze current treatment guidelines for Central Precocious Puberty while offering insights on navigating treatment selection in scenarios lacking established protocols.

The panel explores the impact of early versus delayed diagnosis and treatment initiation on long-term outcomes in Central Precocious Puberty patients.

Lynn Malec, MD, joins Contemporary Pediatrics once again for a discussion of the hemophilia A space and how pediatric health care providers fit into care.

Renowned specialists in central precocious puberty examine the potential psychological and social implications of CPP on affected children.

Expert discussion of several topics including diagnosis, clinical management in older adults, multidrug resistance, and long-acting injectables and PrEP.

Key opinion leaders offer insights into the pathogenesis and essential features of CPP, along with additional symptoms that clinicians should monitor.

Lynn Malec, MD, joined us to discuss the phase 3 XTEND-Kids study of ALTUVIIIO in pediatric patients with hemophilia A.

Erica Prochaska, MD, highlights a recent study that aimed to estimate the rate of HOB among infants admitted to the NICU, measure the association of HOB risk with birth weight group and postnatal age, and estimate HOB-attributable mortality.

Shreya Doshi, MBBS, FAAP, shares how routine screening appointments can serve as a good time to discuss environmental elements with families.

Shreya Doshi, MBBS, FAAP, discusses how contamination could be reducing your practice's recycling impact.

The second episode in our series looks to address clinical management in a time when antimicrobial resistance appears to be growing.

Shreya Doshi, MBBS, FAAP, joined us to discuss some easy opportunities to reduce emissions in your practice and help improve health care sustainability.

This series looks to discuss several topics around these infections including diagnosis, treatment, challenges in managing UTIs in patients with dementia and neurogenic bladders, antibiotic resistance, and considerations for patients and caregiver engagement.

Matthew M. Davis, MD, MAAP, breaks down a newly-published study highlighting a potential association between COVID-19 vaccination and prevalence of symptomatic childhood asthma.

A discussion evaluating how social media can impact an individual's mental health, and what specific elements of social media could be causing it.

Shreya Doshi, MBBS, FAAP, explains what health care sustainability is and how the industry contributes to climate change.

How providers can advocate for increased research determining social media and its association with youth mental health.